Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

704
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
704
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

958
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
958
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

844
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
844
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

1.0K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.0K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

504
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
504

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgery Attendings' Autonomy-Supportive and Controlling Coaching in the Operating Room.

Journal of surgical education·2026
Same author

Evaluation of the Quality of General Surgery Entrustable Professional Activities Using the EQual Rubric.

Journal of surgical education·2025
Same author

Artificial Intelligence in Surgical Education: A 2025 Update on Adaptive Training, Feedback, and Competency-Based Education.

The American surgeon·2025
Same author

Nasogastric tube tune-up: Surgical residents and med-surg nursing achieve proficiency in a standardized protocol after targeted education.

American journal of surgery·2025
Same author

Implementation of entrustable professional activities in multiple surgical residencies: A quality improvement approach.

American journal of surgery·2023
Same author

Forum Theatre to Address Peer-to-Peer Mistreatment in General Surgery Residency.

Journal of surgical education·2022

Related Experiment Video

Updated: Feb 4, 2026

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
06:02

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants

Published on: November 28, 2025

491

Acid Peptic Disease.

Jason W Kempenich1, Kenneth R Sirinek1

  • 1Department of Surgery, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

The Surgical Clinics of North America
|September 24, 2018
PubMed
Summary

Peptic ulcer disease management shifted from surgery to medicine, reducing elective surgeries. However, acute surgical interventions for complications remain significant, requiring surgeon expertise in diverse treatment options.

Keywords:
Bleeding ulcerHelicobacter pyloriObstructing ulcerPeptic ulcer diseasePerforated ulcer

More Related Videos

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.7K
Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

2.3K

Related Experiment Videos

Last Updated: Feb 4, 2026

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
06:02

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants

Published on: November 28, 2025

491
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.7K
Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

2.3K

Area of Science:

  • Gastroenterology
  • Surgical Management
  • Medical Therapy

Background:

  • Peptic ulcer disease (PUD) management has evolved significantly over four decades.
  • Shift from predominantly surgical to medical treatment has drastically reduced elective surgeries.
  • Despite advances, acute surgical interventions for PUD complications persist.

Purpose of the Study:

  • To highlight the changing landscape of peptic ulcer disease management.
  • To emphasize the continued importance of surgical expertise for PUD complications.
  • To underscore the need for acute care surgeons to be knowledgeable in various treatment modalities.

Main Methods:

  • Review of historical and current treatment paradigms for peptic ulcer disease.
  • Analysis of trends in surgical versus medical management.
  • Assessment of the impact of medical advancements on surgical intervention rates.

Main Results:

  • Elective surgical interventions for peptic ulcer disease are now rare.
  • Acute surgical interventions for complications like perforation, bleeding, and obstruction still constitute a notable portion of hospital admissions.
  • Modern acute care surgeons require comprehensive knowledge of diverse treatment strategies.

Conclusions:

  • The management of peptic ulcer disease has transformed, with medical therapy largely replacing elective surgery.
  • Acute surgical care for peptic ulcer disease complications remains critical and necessitates specialized surgeon knowledge.
  • Continuous education in evolving treatment modalities is essential for acute care surgeons managing these patients.